Permira buys from Olympus in first Japanese transaction

Permira is acquiring Arysta LifeScience from rival Olympus Capital in a secondary deal, valuing the agrochemical business at $2.2 billion in Japan's largest buyout this year and Permira’s first in the country.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this